Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49


Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life.

Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P, Donelli A, Filippi M, Guerrasio A, Gualandi F, La Nasa G, Murialdo A, Pagliai F, Papineschi F, Scappini B, Marmont AM.

Blood. 2005 Mar 15;105(6):2601-7. Epub 2004 Nov 16.


Multiple sclerosis.

Hafler DA.

J Clin Invest. 2004 Mar;113(6):788-94. Review.


Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation.

Inglese M, Mancardi GL, Pagani E, Rocca MA, Murialdo A, Saccardi R, Comi G, Filippi M; Italian GITMO-NEURO Group on Autologous Hematopoietic Stem Cell Transplantation.

J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):643-4.


Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis.

Sun W, Popat U, Hutton G, Zang YC, Krance R, Carrum G, Land GA, Heslop H, Brenner M, Zhang JZ.

Brain. 2004 May;127(Pt 5):996-1008. Epub 2004 Feb 25.


Stem cell transplantation for multiple sclerosis: what is the evidence?

Fassas A, Kimiskidis VK.

Blood Rev. 2003 Dec;17(4):233-40. Review.


Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challenges.

Muraro PA, Cassiani Ingoni R, Martin R.

Curr Opin Neurol. 2003 Jun;16(3):299-305. Review.


Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores.

Burt RK, Cohen BA, Russell E, Spero K, Joshi A, Oyama Y, Karpus WJ, Luo K, Jovanovic B, Traynor A, Karlin K, Stefoski D, Burns WH.

Blood. 2003 Oct 1;102(7):2373-8. Epub 2003 Jul 3.


Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin.

Kivisäkk P, Mahad DJ, Callahan MK, Trebst C, Tucky B, Wei T, Wu L, Baekkevold ES, Lassmann H, Staugaitis SM, Campbell JJ, Ransohoff RM.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8389-94. Epub 2003 Jun 26.


Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis.

Hug A, Korporal M, Schröder I, Haas J, Glatz K, Storch-Hagenlocher B, Wildemann B.

J Immunol. 2003 Jul 1;171(1):432-7.


High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

Nash RA, Bowen JD, McSweeney PA, Pavletic SZ, Maravilla KR, Park MS, Storek J, Sullivan KM, Al-Omaishi J, Corboy JR, DiPersio J, Georges GE, Gooley TA, Holmberg LA, LeMaistre CF, Ryan K, Openshaw H, Sunderhaus J, Storb R, Zunt J, Kraft GH.

Blood. 2003 Oct 1;102(7):2364-72. Epub 2003 May 22.


Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT).

Reimer P, Kunzmann V, Wilhelm M, Weissbrich B, Kraemer D, Berghammer H, Weissinger F.

Ann Hematol. 2003 May;82(5):263-70. Epub 2003 Mar 22.


Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infection.

Peggs KS, Verfuerth S, Pizzey A, Khan N, Moss P, Goldstone AH, Yong K, Mackinnon S.

Biol Blood Marrow Transplant. 2003 Mar;9(3):198-205.


CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients.

Carreras E, Saiz A, Marín P, Martínez C, Rovira M, Villamor N, Aymerich M, Lozano M, Fernández-Avilés F, Urbano-Izpizua A, Montserrat E, Graus F.

Haematologica. 2003 Mar;88(3):306-14.


Effects of mitoxantrone on multiple sclerosis patients' lymphocyte subpopulations and production of immunoglobulin, TNF-alpha and IL-10.

Gbadamosi J, Buhmann C, Tessmer W, Moench A, Haag F, Heesen C.

Eur Neurol. 2003;49(3):137-41.


Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells.

Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, Crotty LE, Casazza JP, Kuruppu J, Migueles SA, Connors M, Roederer M, Douek DC, Koup RA.

Blood. 2003 Apr 1;101(7):2711-20. Epub 2002 Nov 14.


Thymic regeneration: teaching an old immune system new tricks.

Berzins SP, Uldrich AP, Sutherland JS, Gill J, Miller JF, Godfrey DI, Boyd RL.

Trends Mol Med. 2002 Oct;8(10):469-76. Review.


Maintaining the norm: T-cell homeostasis.

Jameson SC.

Nat Rev Immunol. 2002 Aug;2(8):547-56. Review. No abstract available.


Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood.

Kimmig S, Przybylski GK, Schmidt CA, Laurisch K, Möwes B, Radbruch A, Thiel A.

J Exp Med. 2002 Mar 18;195(6):789-94.

Supplemental Content

Support Center